Oncology Medical Minute (CME): Targeting the Tumor: Treating the Subtypes of Metastatic Breast Cancer

This article has been archived.
Please use for reference only.

Last Modified: February 3, 2012

Share article

Outcomes for women with metastatic breast cancer can be improved by the effective use of biomarkers and genomic assays to quantify individual risk and guide treatment selection. This continuing medical education activity will enhance the ability of oncologists to develop optimal treatment plans while integrating the latest clinical evidence into practice, ultimately improving outcomes in MBC.

Continue to activity

OncoLink Treatment Binder

Select the side effects and forms for your patient's treatment binder

Learn More

Blogs and Web Chats

OncoLink Blogs give our readers a chance to react to and comment on key cancer news topics and provides a forum for OncoLink Experts and readers to share opinions and learn from each other.

OncoLink OncoPilot

Facing a new cancer diagnosis or changing the course of your current treatment? Let our cancer nurses help you through!

Learn More